Abstract
Use of an absorbable antibacterial envelope reduces cardiac implantable electronic device (CIED) infection in patients undergoing implantation, revision, replacement or upgrade. The risk of infection during these procedures is estimated from 1-4% and increases for patients with high-risk factors. We evaluated the cost-effectiveness of the antibacterial envelope in Mexican public institutes in high-risk patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
